How many institutions held DRMA - Dermata Therapeutics, Inc. - Common Stock, $0.0001 par value in Q4 2022?

11 institutional investors reported DRMA - Dermata Therapeutics, Inc. - Common Stock, $0.0001 par value for Q4 2022. Use the holders table for investor-level position and value details.

Dermata Therapeutics, Inc. - Common Stock, $0.0001 par value (DRMA)

Q: What does CUSIP 249845108 represent in this 13F holders report?

CUSIP 249845108 is the security identifier for DRMA - Dermata Therapeutics, Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

CUSIP: 249845108

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / Common Stock, $0.0001 par value
Total 13F shares: 292,762
Total 13F value: $118,779
Share change: +95,560
SEC-reported price per share: $0.41
Number of holders: 11
Value change: +$27,793
Number of buys: 7
Number of sells: 4
Shares outstanding: 4,021,390

Security key

249845108

Report period

Q4 2022

Institutions

Top holders

DRMA full security history Ownership snapshot Full 13F holder table Dermata Therapeutics, Inc. SEC filings Dermata Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of DRMA - Dermata Therapeutics, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Virtu Financial LLC

Disclosed value leader

Proehl Investment Venture...

Comparable rows

8/15

Latest evidence

30 Sep 2022

13F 3/4/5 Lead comparable stake: 1.8% 7 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Virtu Financial LLC leads the comparable SEC ownership view at 1.8%.

8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Virtu Financial LLC's linked filing trail.

Comparable ownership Top 5

Virtu Financial LLC 1.8%

GEODE CAPITAL MANAGEMENT, LLC 0.66%

WELLS FARGO & COMPANY/MN 0.61%

JANE STREET GROUP, LLC 0.59%

Sage Capital Advisors,llc 0.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Virtu Financial LLC	13F Company 13F	1.8%	$37,000 70,808 shares	—	30 Sep 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.66%	$13,000 26,666 shares	—	30 Sep 2022
WELLS FARGO & COMPANY/MN	13F Company 13F	0.61%	$13,000 24,388 shares	—	30 Sep 2022
JANE STREET GROUP, LLC	13F Company 13F	0.59%	$12,000 23,565 shares	—	30 Sep 2022
Sage Capital Advisors,llc	13F Company 13F	0.3%	$6,000 12,000 shares	—	30 Sep 2022
TUDOR INVESTMENT CORP ET AL	13F Company 13F	0.25%	$5,000 10,205 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

292,762

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %